By visiting our website or using services provided by Sai Life Sciences, you are accepting the practices described in the Privacy Policy.

We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. By continuing to use this website, you agree that we may store and access cookies on your device.

By clicking “I Accept”, you confirm that you are above the age of 16, that you have read and understood the Cookies Usage and the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Sai Life in accordance with said policies.

I accept

Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

Investors

Sai Life Sciences is a full-service CRDMO empowering global pharmaceutical and biotech innovators across the development lifecycle. With strategic investments in high-potency capabilities, digital platforms, and sustainability, we are evolving to meet the demands of next-generation molecules. Our strong customer relationships, operational agility, and commitment to responsible growth position us to deliver consistent performance and long-term stakeholder value.

Investor Relations

Financial Performance Highlights

Sai Life Sciences' modern industrial facility at sunset, representing innovation, growth, and commitment to excellence for investors.
Sai Life Sciences' modern industrial facility at sunset, representing innovation, growth, and commitment to excellence for investors.

Disclosure under regulation 46

Outcome of Board Meeting - 07 August 2025

Details of Business

Outcome of Board Meeting - 06 February 2025

Financial Results - Quarter ending December 2024

Newspaper Advertisements - Results for Dec 31st 2024

Outcome of Board Meeting - 13 May 2025

Financial Results - Quarter ending March 2025

Newspaper Advertisements - Results for Mar 31st 2025

Monitoring agency report - Dec 31st 2024

Statement of deviation - Dec 31st 2024

Monitoring agency report - Mar 31st 2025

Investor contact

ESOP Scheme 2008

ESOP Scheme 2018

Notice of Postal Ballot – 15th May 2025

Newspaper Advertisements - Postal Ballot

Postal Ballot – Outcome and Scrutinizer report

Credit Rating 15 May 2024

Disclosure under regulation 30

Allotment of Equity Shares 23.07.2025

Sai Meeting Intimation 13 and 14 August 2025 Avendus Spark INDX

Proposed Capacity Addition

Investor Meet Intimation ALF Accurate

Investor Meet Intimation Kotak 18th Feb

Investor Meet Intimation Kotak

Investor Meet Intimation with Capital Group Investment Management

Allotment of Equity Shares on conversion of ESOP

10.03.2025 ESOP conversion into Equity

Reg 30 Change in Management and Allotment of Shares 24.03.2025

Reg 30 IT Demand Notice

Reg 30 Order MHVAT

Reg 30 Resignation of Mitesh Daga

Reg30 SEBI Allotment of Equity Shares 20.03.2025

Sai_Meeting_Intimation_06032025_1 PGIM

Sai_Meeting_Intimation_06032025_2 Nippon Life India

Sai_Meeting_Intimation_06032025_3 Invesco

Sai_Meeting_Intimation_06032025_4 Aditya Birla Sun Life

Sai_Meeting_Intimation_06032025_5 DSP

Sai_Meeting_Intimation_06032025_6 BlackRock

Sai_Meeting_Intimation_07032025 Creaegis

Sai_Meeting_Intimation_25032025_1 Goldman Sachs

Sai_Meeting_Intimation_25032025_2 T. Rowe

Sai_Meeting_Intimation_25032025_3 Amansa

Sai_Meeting_Intimation_26032025_1 Ward Ferry

Sai_Meeting_Intimation_26032025_2 GIC

Sai_Meeting_Intimation_26032025_3 M&G Investments

Sai_Meeting_Intimation_26032025_4 White Oak

Sai_Meeting_Intimation_26032025_5 Fidelity

Sai_Meeting_Intimation_26032025_6 Capital Research

Sai_Meeting_Intimation_27032025_1 Franklin Templeton

Sai_Meeting_Intimation_27032025_2 Eastspring

Sai_Meeting_Intimation_27032025_3 Qatar

Sai_Meeting_Intimation_27032025_4 Capital World

Sai_Meeting_Intimation_27032025_5 Kotak Offshore

Sai_Meeting_Intimation_28032025_1 DSP

Sai_Meeting_Intimation_28032025_2 Invesco

Sai_Meeting_Intimation_28032025_3 Aditya Birla Capital

Sai_Meeting_Intimation_28032025_4 Enam

Sai_Meeting_Intimation_28032025_5 HDFC Asset

Allotment of Equity shares 23.04.2025

Change in Designation of SMP

Allotment of Equity shares 23.04.2025

Reg 30 App of Siva as Director

Allotment of Securities 13.05.2025

Sai_Meeting_Intimation_04062025_Emkay_Global

Sai_Meeting_Intimation_04062025_Group_Meeting_11AM

Sai_Meeting_Intimation_04062025_Group_Meeting_12PM

Sai_Meeting_Intimation_04062025_Group_Meeting_145PM

Sai_Meeting_Intimation_11062025_C_Worldwide_Asset_Management

Sai_Meeting_Intimation_17062025_Group_Meeting

Sai_Meeting_Intimation_19062025_Group_Meeting

Sai_Meeting_Intimation_24062025_IIFLs-Invest-India

Sai_Meeting_Intimation_30052025_Columbia_Threadneedle

Commencement_Of_Commercial_Operation_Second_Phase_Bidar_Facility

Alottment_of_Shares_26.06.2025

Revised_Alottment_of_Shares_27.06.2025